Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ecabet Sodium and PPI for Iatrogenic Ulcer after ESD
NCT01308177Phase 4Unknown
- Sponsor
- Samsung Medical Center
- Start
- Mar 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ecabet sodium in Peptic ulcer disease (PUD), sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
ecabet sodium
03
Conditions
Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT01308177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01308177.